Myriad Genetics, Inc. (MYGN)
4.54
+0.48
(+11.82%)
USD |
NASDAQ |
Oct 02, 16:00
4.54
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Profit Margin (Quarterly) : -22.65% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -22.65% |
| March 31, 2026 | -17.02% |
| December 31, 2025 | -3.77% |
| September 30, 2025 | -13.32% |
| June 30, 2025 | -155.1% |
| March 31, 2025 | -0.05% |
| December 31, 2024 | -20.18% |
| September 30, 2024 | -10.36% |
| June 30, 2024 | -17.35% |
| March 31, 2024 | -12.86% |
| December 31, 2023 | -15.87% |
| September 30, 2023 | -31.94% |
| June 30, 2023 | -63.27% |
| March 31, 2023 | -30.19% |
| December 31, 2022 | -23.79% |
| September 30, 2022 | -22.44% |
| June 30, 2022 | -7.86% |
| March 31, 2022 | -12.43% |
| December 31, 2021 | -4.73% |
| September 30, 2021 | 14.70% |
| June 30, 2021 | -2.48% |
| March 31, 2021 | -22.82% |
| June 30, 2020 | -59.55% |
| March 31, 2020 | -70.24% |
| December 31, 2019 | -4.25% |
| Date | Value |
|---|---|
| September 30, 2019 | -11.06% |
| June 30, 2019 | -2.00% |
| March 31, 2019 | 3.19% |
| December 31, 2018 | 1.20% |
| September 30, 2018 | -0.40% |
| June 30, 2018 | 7.48% |
| March 31, 2018 | 4.92% |
| December 31, 2017 | 16.44% |
| September 30, 2017 | 44.02% |
| June 30, 2017 | 6.33% |
| March 31, 2017 | 2.13% |
| December 31, 2016 | 3.00% |
| September 30, 2016 | -0.68% |
| June 30, 2016 | 12.55% |
| March 31, 2016 | 18.11% |
| December 31, 2015 | 15.68% |
| September 30, 2015 | 14.50% |
| June 30, 2015 | 9.85% |
| March 31, 2015 | 11.93% |
| December 31, 2014 | 13.03% |
| September 30, 2014 | 9.47% |
| June 30, 2014 | 17.82% |
| March 31, 2014 | 20.10% |
| December 31, 2013 | 24.68% |
| September 30, 2013 | 27.39% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Natera, Inc. | -8.90% |
| Sera Prognostics, Inc. | -30.46K% |
| BioRestorative Therapies, Inc. | -9.29K% |
| CareDx, Inc. | 83.85% |
| Exagen, Inc. | -16.03% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -31.80% |
| Return on Assets | -16.44% |
| Return on Invested Capital | -20.33% |
| Gross Profit Margin (Quarterly) | 62.51% |
| Operating Margin (Quarterly) | -20.40% |
| Return on Net Operating Assets | -21.42% |